CCME Global sets board meeting to approve fiscal 2026 results
Routine disclosure for upcoming Q4 and FY26 audit; no strategic updates flagged.
Mkt cap₹566 cr
ROE41.08%
Debt / eq.0.00
March 31, 2026 Fiscal year-end date covered by upcoming board approval.
What's new
- Board meeting set for upcoming audited financial results.
- Covers Q4 and full-year FY26 performance.
- Routine procedural filing with no material new details.
Why this matters
The filing is purely administrative. It contains no information on performance or strategy.
What we're watching
- The actual release of audited financials after the board meeting.
- Potential material updates following recent preferential allotments.
The full read
CCME Global has issued a standard procedural intimation regarding an upcoming board meeting to approve its audited financial results for the quarter and year ending March 31, 2026. This filing carries no material new information. It is a routine regulatory requirement under SEBI standards. Despite the company's recent activity involving name changes and preferential share allotments, this notice provides no insight into performance or future direction. The investment thesis remains unchanged until the board convenes and the results are published.
Mentioned: CCME Global Ltd.
Company snapshot
CCME Global Ltd.
Chemicals
₹529 cr
Latest quarter · Dec 2025
Sales₹0 cr
Net profit−₹0 cr
Op. margin+0.0%
EPS−₹0.02
Strength & growth
Debt / equity0.00×
Current ratio29.18×